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Abstract 
Oral mucositis is one of the main complications of non-surgical cancer 
treatments. The present work focuses on the treatment or reduction of oral 
mucositis by using combined mechanism by formation of physical barrier by 
forming a film to cover the oral ulcer and use of therapeutic agents, such as 
diclofenac sodium and ofloxacin separately or in combination. The selected 
polymers for film forming gel formulations are Hydroxypropylcellulose 
(HPC), hydroxypropyl methylcellulose (HPMC), sodium 
carboxymethylcellulose (Na CMC) and carbopol 940 (CP). The residence 
time in simulated buccal saliva was between 5.5 to 6 hours for all 
formulations. The in-vitro release data of the investigated drugs from the 
prepared formulations followed zero-order and diffusion mechanism. The 
permeability studies data revealed that diclofenac sodium showed higher 
permeability from Na CMC/CP (2:0.3%) than from HPMC 4%, while in case 
of ofloxacin higher permeability was shown from Na CMC/CP (2:0.3%) than 
from HPMC/HPC (2:3%). The permeation parameters for diclofenac sodium 
and ofloxacin in their combination do not depend on either viscosity or pH, 
they depend on the type of polymers used. 
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Introduction  
Mucositis induced by anti-neoplastic drugs is an 
important, dose-limiting, and costly side effect of 
cancer therapy. The ulcerative lesions produced by 
mucotoxic chemotherapy are painful, restrict oral 
intake and, importantly, act as sites of secondary 
infection of oral flora [1]. 
Previously published data [2-8] have pointed out that 
the prophylaxis and treatment of oral mucositis during 
cancer therapies remain an unsolved problem. 
Pretreatment assessment of oral cavity hygiene and 
mouthwashes seem to be effective in preventing the 
onset of oral mucositis [9]. Some therapeutic agents, 
such as benzydamine, imidazole antibiotic, triazolic 
antimycotic  and  povidone  iodine  have  shown some  
 
 
 
clinical evidence of their efficacy in reducing oral 
mucositis.Bioadhesive polymers appear to be 
particulary attractive for the development of drug 
delivery systems to improve intraoral administration 
[10-14] and reduce the frequency of application and 
the amount of drug administered. Gels and films may 
be most suitable for this type of application and they 
are able to cover a wide area of mucosa for both drug 
delivery and physical protection [15, 16]. The aim of 
this study was to develop a film forming gel system 
containing diclofenac sodium, ofloxacin and their 
combination for prophylaxis and/or treatment of oral 
mucositis. Film forming gel formulations were 
prepared  using  mucoadhesive  polymer  to produce a  
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physical barrier around the ulcers and form a 
medicated film for delivery of either diclofenac 
sodium or ofloxacin to treat the formed ulcer.  
 
Materials and methods 
 Materials 
Diclofenac sodium (Delta pharmaceuticals, Cairo, 
Egypt), ofloxacin (El Kahira Co. Cairo, Egypt), 
hydroxypropylcellulose MF (Kolmar, California, 
USA), hydroxyl propylmethylcellulose E4M (Dow 
Chemical Co., USA), sodium carboxymethylcellulose  
(BDH Chemicals, Ltd, Poole, UK), carbopol 940 
(Sedico pharmaceuticals, Cairo, Egypt). All other 
chemicals were of analytical reagent grade. 
 
Formulation and preparation of the gels 
The gels were obtained using different mucoadhesive 
polymers, diclofenac sodium, ofloxacin (active 
compounds) and their combination were incorporated 
into the formulations. Composition of the different 
gels is shown in table 1.  
 
 
 
Table 1. Composition (% w/w), pH, residence time and bioadhesive force of the film forming gel. 
 
Formula 
Code Polymer Type 
Polymer 
Concentration pH 
Residance 
Time (hr) 
Bioadhesive 
Force (cm) 
1 HMPC 4% 6.76 6 1.5 
2 HMPC/HPC 2:3% 6.42 5.5 4.5 
3 HMPC/HPC 3:3% 6.32 5.5 3 
4 HMPC/HPC 4:3% 6.71 6 2 
5 HPC 16% 7.1 5.5 5 
6 HPC/CP 4:0.3% 7.7 6 2.5 
7 Na CMC/CP 2:0.3% 7.3 6 1.5 
 
HPMC, Hydroxyprpyl methyl cellulose; HPC, Hydroxyprpyl cellulose; CP, Carbopol 940; Na CMC, Sodium carboxymethyl cellulose. 
 
The polymers were dispersed in 60 % ethanol. 
Incorporation of 0.1%w/w diclofenac sodium, or 
0.5% w/w ofloxacin or their combination was 
performed by dispersing them in water at 50-60 ˚C 
and then pouring this dispersion onto the polymer 
mixture under slow stirring for 20 min. Propylene 
glycol was incorporated to increase the solubility of 
ofloxacin. Dispersion was mixed using a magnetic 
stirring bar till a clear transparent gel free from air 
bubbles was formed. pH measurement was  carried 
out using pH meter 3510, Jenway, Essex, (England). 
 
Residence time of the gels 
The time taken by the film formed from different gel 
formulations, after evaporation of the vehicle; to 
dissolve  was monitored for 6 hours in simulated 
saliva by applying 1 gm of the gel on the centre of a 
watch glass, making a circle of 3 cm in diameter left 
until dryness. Six ml of simulated saliva were added 
on two portions to simulate the buccal cavity. 
 
 
Bioadhesivness of the gels 
The force required to overcome the attraction force 
between the surface and the sample (adhesiveness) 
was measured by the plate agar method which 
showed the bio-adhesiveness of the gel [17]. A plate 
containing agar (2% w/v) of 5 cm diameter was 
prepared, 0.5 gm of the gel was placed on the centre 
of the agar plate, making a circle of 5 mm in 
diameter. The plate was slanted at 30˚ for 1 hour and 
the longest distance moved by the gel was measured 
at room temperature. 
 
Rheological properties of the gels 
The rheological properties of film forming gel were 
evaluated using Bohlin Gemni 200 Rheometer at 
25˚C using 1 g of a sample. In order to identify the 
flow behavior of each gel base, viscosity was 
determined at different shear rates to generate a 
complete flow curve by plotting viscosity versus 
shear rate. 
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Fourier transform infrared spectrophotometry 
(FTIR) 
FTIR spectra of the polymer used, diclofenac sodium, 
ofloxacin alone and in the gel formulations were 
recorded on Nicolet Avatar 380 spectrometer. 
Attenuated total reflection method was adopted using 
a diamond crystal as an internal reflection element. 
 
Gel stability 
Stability of the gel formulations was also 
investigated. The organoleptic properties (color, 
odor), pH, and drug content of the gels stored at 40 ˚C 
were examined for 3 months. Drug content for 
diclofenac sodium and ofloxacin alone was measured 
spectrophotometrically at 277 and 290 nm 
respectively. Their combination was measured using 
HPLC method at 280 nm. 
 
In vitro drug release 
The in vitro release data were fitted to different 
models; the following mathematical equations were 
used: 
Zero-order kinetic model 
       M0 −Mt = k0t                                                 (1) 
First-order model 
       Ln M0/ Mt= K1t                                             (2) 
Higuchi model 
       Mt = KH t1/2                                                                             (3) 
where M0 and Mt correspond to the amount of drug 
taken at time zero, or dissolved at a particular time t. 
k0, k1 and KH the release kinetic constants obtained 
from the linear curves of the zero-order, first-order 
and Higuchi model, respectively [18,19] . 
The release of drugs from gels was performed 
through a dialysis membrane (Fischer cellophane 
membrane 30/32), which was placed in continuously 
stirred 50-ml simulated saliva (pH 7.5) [disodium 
hydrogen phosphate (2.38g/L), potassium dihydrogen 
phosphate (0.19g/L) and sodium chloride (8g/L)] at 
37±0.5 ˚C [20]. At appropriate time intervals, a 5-ml 
sample was withdrawn and replaced with the same 
amount of fresh simulated saliva. 
 
In vitro permeation study 
Franz diffusion cell with a 3.14-cm2 diffusion area 
and 16-ml receptor volume were used to study the 
permeability of the incorporated drugs. The excised 
rat peritoneal membranes were placed between the 
donor and receptor compartments of the cells. 
Approximately16 ml of simulated saliva (pH 7.4) was 
placed in the receptor compartment. Its temperature 
was maintained at 37 ± 0.5˚C and it was stirred at 50 
rpm throughout the experiment. The donor 
compartment contained 1 g of the sample. At 
appropriate time intervals, a 2-ml sample was 
withdrawn and replaced with the same amount of 
simulated saliva. The diclofenac sodium 
concentration in the samples was determined 
spectrophotometrically, using UV spectrophotometer 
6315, Jenway, Essex, (England) at 277 nm against a 
blank prepared with the permeated formulation 
without the drug [21]. Ofloxacin concentrations was 
determined spectrophotometrically at 290 nm against 
a blank prepared with the permeated formulation 
without the drug (Park et al., 2000), while the 
combined samples was determined using a modified 
HPLC method at 280 nm [22]. Three replicates of 
each experiment were performed. 
 
Results and discussion 
Residence time of the gels 
Residence time in simulated buccal saliva shown in 
Table 1 is 6 hours for formulations of Na CMC/CP 
(2:0.3%) and HPMC (4%) while HPC (3%) in 
combination with HPMC (2%) and (3%), and 
HPC/CP (4:0.3%) is 5.5 hours. Finally, HPMC/HPC 
(4:3%) and HPC (16%) is only 5 hours. 
 
Bioadhesivness of the gels 
The bio-adhesiveness data shown in table 1  revealed 
that the most adhesive gels are Na CMC/CP (2:0.3%), 
HPMC (4%), and HPC/CP (4:0.3%) followed by 
HPC (3%) in combination with HPMC (3%) and 
(4%). The least adhesive gels are HPMC/HPC (2:3%) 
and HPC (16%).  
 
Rheological properties of the gels 
The rheological data is shown in figure1-3 revealed 
that all film forming gel formulations exhibited shear 
thickening behavior at low shear rates followed by 
shear thinning at high shear rates, except for HPC 
(16%) and HPMC/HPC (2:3%) showed Newtonian 
flow. The highest viscosity was recorded for 
formulations of HPMC (4%), HPMC/HPC (3:3%) 
and (4:3%), and Na CMC/CP (2:0.3%). Figure 4 -6 
represent a relation between shear rate and shear 
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stress of different film forming gel. The formulations 
showed pseudoplastic flow. 
 
Figure 1. Viscosity of different film forming gels 
containing diclofenac sodium in HPMC 4% (♦), 
HPMC 2%: HPC 3% (), HPMC 3%:HPC 3% 
(▲), HPMC 4%:HPC 3% (○), HPC 16% (●), HPC 
4%:CP0.3% (Δ) and NaCMC 2%:CP 0.3% (×) as 
function of shear rate. 
 
Fourier transform infrared spectrophotometry 
(FTIR) 
The IR data revealed that there was no significant 
interaction between diclofenac sodium, ofloxacin and 
polymer used. The bands due to diclofenac sodium 
especially in the range 3600-3000 cm-1 are not clear 
in the spectrum of the diclofenac sodium and its 
combination with ofloxacin. 
 
Figure 2. Viscosity of different film forming gels 
containing ofloxacin in HPMC 4% (♦), HPMC 
2%: HPC 3% (), HPMC 3%:HPC 3% (▲), 
HPMC 4%:HPC 3% (○), HPC 16% (●), HPC 
4%:CP0.3% (Δ) and Na CMC 2%:CP 0.3% (×) as 
function of shear rate. 
 
This could be explained on the basis that diclofenac 
sodium band overlapped with the broad O-H band of 
hydroxypropylmethylcellulose appeared in this 
region. On the other hand, ofloxacin does not interact 
in any way with the polymer used. 
 
 
Figure 3. Viscosity of different film forming gels 
containing diclofenac sodium and ofloxacin in 
HPMC 4% (♦), HPMC 2%: HPC 3% (), HPMC 
3%:HPC 3% (▲), HPMC 4%:HPC 3% (○), HPC 
16% (●), HPC 4%:CP0.3% (Δ) and Na CMC 
2%:CP 0.3% (×) as function of shear rate. 
 
Gel stability 
Stability studies were conducted at 40˚C. All the gel 
formulation tested remained stable after 3 months of 
storage at 40˚C. 
 
Figure 4. Rheogram of film forming gels 
containing diclofenac sodium in HPMC 4% (♦), 
HPMC 2%:HPC 3% (), HPMC 3%:HPC 3% 
(▲), HPMC 4%:HPC 3% (○), HPC 16% (●), HPC 
4%:CP0.3% (Δ) and Na CMC 2%:CP 0.3% (×). 
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In vitro release study 
The kinetics of drug release was studied in different 
formulations. Preference of a certain mechanism was 
based on the correlation coefficient for the parameters 
involved.  The kinetic analysis of the release data 
reveals that diclofenac sodium, ofloxacin and their 
combination in different film forming gel were 
released by zero order and diffusion mechanism for 
the 6 hours of the study. This could be attributed to; 
release was first from the gel applied, after that the 
release was from a thin film formed as the alcohol 
evaporated from the gel. The release of diclofenac 
sodium shown in figure 7 from film forming gel 
based on HPMC (4% w/w) and HPC (16% w/w) 
alone was higher than those containing both polymers 
(different concentrations of HPMC with fixed 
concentration of HPC (3% w/w)).  
 
 
 
Figure 5. Rheogram of film forming gels 
containing ofloxacin in HPMC 4% (♦), HPMC 
2%:HPC 3% (), HPMC 3%:HPC 3% (▲), 
HPMC 4%:HPC 3% (○), HPC 16% (●), HPC 
4%:CP0.3% (Δ) and Na CMC 2%:CP 0.3% (×). 
 
This may be due to the differences in wettability 
between HPMC and HPC which led to a decrease in 
the entrance of water through the polymer [23]. The 
release from HPC (16% w/w) alone (75.7%) was 
higher than its combination with carbopol (37.7%). 
This could be explained on the higher viscosity of 
HPC film forming gel in presence of carbopol (158.8 
Pas) in comparison to HPC alone (16.72 Pas). The 
release from film forming gel composed of Na 
CMC/CP (2:0.3%) was the highest compared to other 
gel formulations (98.7%). This result is in agreement 
with the previous finding [23]. At pH 6.8, the Na 
CMC gel has a loose structure where the weak gel 
structure determines the ability of the polymer chains 
to disentangle from the polymer network and to 
dissolve. This results in faster erosion of the hydrogel 
and enhances drug release. The release of ofloxacin 
shown in figure 8 was high from HPMC/HPC (2:3%) 
due to the low viscosity of this formulation. On the 
other hand, the presence of carbopol in combination 
with HPC (4%) potentiated the rapid release of 
ofloxacin from the gel due to its high hydrophilicity, 
while HPC only retarded ofloxacin release. Also, the 
release from Na CMC/CP gel recorded a very high 
release percentage. 
 
Figure 6. Rheogram of film forming gels 
containing diclofenac sodium and ofloxacin in 
HPMC 4% (♦), HPMC 2%:HPC 3% (), HPMC 
3%:HPC 3% (▲), HPMC 4%:HPC 3% (○), HPC 
16% (●), HPC 4%:CP0.3% (Δ) and Na CMC 
2%:CP 0.3% (×). 
 
The data presented in figure 9 revealed that the 
presence of ofloxacin decreased the cumulative 
percent released of diclofenac sodium from three 
formulations: HPMC 4%, HPC 16%, and Na 
CMC/CP (2:0.3%), while showing no effect on the 
rest of formulations. Also, it was observed that the 
presence of diclofenac sodium increased the 
cumulative percent released of ofloxacin shown in 
Fig.10 from four formulations: HPMC (4%), 
HPMC/HPC (3:3%), HPMC/HPC (4:3%) and HPC 
(16%), while decreasing the release from the rest of 
formulations. 
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Figure 7: Release profile of diclofenac sodium 
(0.1%w/w) from different film forming gels in 
HPMC 4% (♦), HPMC 2%:HPC 3% (), HPMC 
3%:HPC 3% (▲), HPMC 4%:HPC 3% (○), HPC 
16% (●), HPC 4%:CP0.3% (Δ) and Na CMC 
2%:CP 0.3% (×). 
 
Permeability study 
The formulations which gave good results with 
highest release percentage were selected for 
permeability studies. To calculate the permeation 
parameters of the Fick’s law equation a graph of 
penetrated amounts vs. time was plotted.  It is 
possible to calculate the steadystate flux (J) from the 
slope of the linear portion (2-6 hours) of the graph 
[24, 25]. 
 
  
 
Figure 8: Release profile of ofloxacin (0.5%w/w) 
from different film forming gels in HPMC 4% (♦), 
HPMC 2%:HPC 3% (), HPMC 3%:HPC 3% 
(▲), HPMC 4%:HPC 3% (○), HPC 16% (●), HPC 
4%:CP0.3% (Δ) and Na CMC 2%:CP 0.3% (×). 
 
 
Figure 9: Release profile of diclofenac sodium 
(0.1%w/w) from its combination with ofloxacin 
(0.5%w/w) in different film forming gels in HPMC 
4% (♦), HPMC 2%:HPC 3% (), HPMC 
3%:HPC 3% (▲), HPMC 4%:HPC 3% (○), HPC 
16% (●), HPC 4%:CP0.3% (Δ) and Na CMC 
2%:CP 0.3% (×). 
 
The permeability coefficient (Kp) was calculated 
from the steady-state flux and the applied 
concentration in the donor compartment (C donor) as 
follows: 
Kp = J/C donor 
 
Figure 10: Release profile of ofloxacin (0.5%w/w) 
from its combination with diclofenac sodium 
(0.1%w/w) in different film forming gels in HPMC 
4% (♦), HPMC 2%:HPC 3% (), HPMC 
3%:HPC 3% (▲), HPMC 4%:HPC 3% (○), HPC 
16% (●), HPC 4%:CP0.3% (Δ) and Na CMC 
2%:CP 0.3% (×). 
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Table 2.  Permeation parameters of diclofenac sodium and ofloxacin delivered from different film forming 
gel formulations. 
 
 
 
The flux and permeability coefficients of the 
formulations are given in Table 2. It is clear that there 
is a correlation between viscosity and permeation 
parameters such as HPMC (4% w/w) containing 
diclofenac sodium with viscosity value (828.2 Pas) 
has low permeability coefficient (0.99 x10-2 cm.hr -1) 
in comparison with Na CMC/CP (2:0.3% w/w) 
formulation with permeability value (1.7 x10-2 cm.hr -
1) having viscosity equal to 177.1 Pas.  
In case of HPMC/HPC (2:3% w/w) [pH=6.9] with 
low viscosity value (34.6 Pas) has low permeation 
parameter for ofloxacin (flux 35.9 μg.cm-2hr-1; 
Permeability coefficient (0.76 x10-2 cm.hr-1) than the 
formulation of Na CMC/CP (2:0.3% w/w) [pH=7.8] 
with high viscosity (589.1 Pas). This could be 
attributed to the role of pH on the solubility of 
ofloxacin. In case of combined samples, there was a 
faster permeation of ofloxacin than diclofenac sodium 
which is attributed to the differences in solubility of 
both drugs in lipoidal membrane. Since ofloxacin 
solubility in water is less than diclofenac sodium, 
therefore its solubility in the membrane is higher than 
the solubility of diclofenac sodium. 
 
Conclusion 
Film forming gels were successfully formulated with 
different polymers (Na CMC, HPC, HPMC and 
carbopol). The most appropriate formulation that was 
compatible with the requirements of providing 
sufficient adhesion, drug release and flux was that 
formulated in Na CMC/CP (2:0.3%).  
This formulation appears to be promising as an 
effective base for delivering diclofenac sodium and 
ofloxacin for treatment and reduction of oral 
mucositis. 
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